18 August 2026
Sobriety platform's free trial signups nearly double over 30 days.
Building a sobriety platform combining peer support, AI, and therapy.
13 August 2026
Mobile MRI startup joins the portfolio of Robinhood Ventures Fund II, the Y Combinator-focused fund that began NYSE trading on 13 August.
Making compact mobile MRI screening accessible outside traditional imaging centers.
10 August 2026
Health testing marketplace launches clinical-grade 30x whole genome sequencing, with members receiving a downloadable genome file they own.
Offering at-cost biomarker testing with AI-guided preventive health insights.
HYBRD passes 5 million workouts logged by its athletes.
Building coaching agents for hybrid athletes.
31 July 2026
Health testing marketplace launches 10 allergy and exposure panels alongside 600+ individual tests spanning food, environmental, and venom triggers.
Offering at-cost biomarker testing with AI-guided preventive health insights.
28 July 2026
Athletes using the app's AI coach retain and convert to paying customers at more than four times the rate of athletes who do not use it.
Building coaching agents for hybrid athletes.
23 July 2026
Hybrid-training app launches on Apple Watch, sending planned workouts to the wrist and adapting them to what users finish.
Building coaching agents for hybrid athletes.
16 July 2026
NOXXEA’s first prospective real-world clinical study reported a mean 7.32-point reduction in Insomnia Severity Index scores after four weeks of treatment.
Building Noxxea, a digital medicine for chronic insomnia.
10 July 2026
At-home diagnostics startup secured €5M in financing, comprising €3M in equity led by Blue Forest Ventures and €2M in non-dilutive funding.
Building rapid point-of-need molecular diagnostics for early Lyme disease detection.
3 July 2026
CNS gene-delivery startup wins Servier x BioLabs Golden Ticket for its blood-brain barrier delivery platform.
Using focused ultrasound and microbubbles to help gene therapies reach the brain.
2 July 2026
Granza Bio wins Best Pitch and Best Scientific Explanation at the 2026 BioEscalator Pitch Battle.
Reprogramming immunity to create target-specific medicines.
Flex Capital invests in Ditto Bio’s evolutionary intelligence platform for autoimmune disease.
Discovering autoimmune-disease drugs from parasite immune-evasion biology.
Early Lyme test hits Boston subway ads to recruit patients after tick bites.
Building rapid point-of-need molecular diagnostics for early Lyme disease detection.
1 July 2026
Health testing marketplace launches on Product Hunt with Y Combinator CEO Garry Tan as hunter.
Offering at-cost biomarker testing with AI-guided preventive health insights.
26 June 2026
HYBRD blows past 500 five-star App Store reviews.
Building coaching agents for hybrid athletes.
23 June 2026
Surgical robotics startup wins VivaTech Startup Challenge award for making brain, spine, and orthopedic surgery more accessible.
Developing robotic systems for AI-assisted bone surgery.
Chronic insomnia program reaches 1,000 prescribed patients and reports 73% clinical effectiveness after 28 days.
Building a digital medicine for chronic insomnia.
18 June 2026
Mobile MRI startup lands on TechCrunch’s list of YC Demo Day standouts.
Making compact mobile MRI screening accessible outside traditional imaging centers.
17 June 2026
European Commission backs human milk ingredients startup with €2.5M EIC Accelerator grant.
Producing human breast-milk components in the lab.
16 June 2026
Cancer gene therapy startup raises $9.1M seed round to advance its glioblastoma program toward clinical trials.
Engineering viruses that teach the immune system to kill brain tumors.